A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2002
10/17/2002	DE10116197A1 New lipid-soluble methylprednisolone 21-ester derivatives, useful as antiinflammatory, immunosuppressive or antiallergic agents, especially in liposome formulations or lipid coatings on implants
10/17/2002	CA2827167A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
10/17/2002	CA2810326A1 Vaccine composition
10/17/2002	CA2762966A1 Hsa-free formulations of interferon-beta
10/17/2002	CA2727715A1 Vaccine composition
10/17/2002	CA2606839A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
10/17/2002	CA2446462A1 Chimeric vaccines
10/17/2002	CA2443694A1 Anti-cd19 immunotoxins
10/17/2002	CA2443372A1 Immunotherapeutic combinations for the treatment of tumors that over-express gangliosides
10/17/2002	CA2443334A1 Protein modification and maintenance molecules
10/17/2002	CA2443330A1 Anti-osteopontin antibody and use thereof
10/17/2002	CA2443099A1 Uses of benzylideneamino guanidines as ligands to the melanocortiin receptors
10/17/2002	CA2443092A1 Use of n-phenyl-2-pyrimidineamine derivatives against mast cell-based diseases like allergic disorders
10/17/2002	CA2443057A1 Novel benzylideneamino guanidines and their uses as ligands to the melanocortin receptors
10/17/2002	CA2443015A1 Aryl (or heteroaryl) azolylcarbinole derivatives for the treatment of respiratory diseases
10/17/2002	CA2442776A1 Antagonists of mcp-1 function and methods of use thereof
10/17/2002	CA2442739A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/17/2002	CA2441499A1 Method for producing a vaccine
10/17/2002	CA2441442A1 Conjugate of hydroxyalkyl starch and an active agent
10/17/2002	CA2440724A1 Pyrazolopyrimidines as therapeutic agents
10/16/2002	EP1249490A2 In vitro activation of cytotoxic T cells
10/16/2002	EP1249456A1 Novel peptide and screening method by using the same
10/16/2002	EP1249450A1 Benzimidazole derivatives
10/16/2002	EP1248858A1 Antisense modulation of caspase 8 expression
10/16/2002	EP1248847A1 Irak-4: compositions and methods of use
10/16/2002	EP1248842A1 2871 receptor, a g-protein coupled receptor and methods of use thereof
10/16/2002	EP1248836A2 Hybrid cells obtainable from antigen presenting cells
10/16/2002	EP1248804A2 Recombinant antibodies to human interleukin-1 beta
10/16/2002	EP1248802A2 Soluble ctla4 mutant molecules and uses thereof
10/16/2002	EP1248801A1 Human polynucleotides, polypeptides, and antibodies
10/16/2002	EP1248795A1 Antisense modulation of macrophage migration inhibitory factor expression
10/16/2002	EP1248791A1 Antisense modulation of caspase 3 expression
10/16/2002	EP1248787A2 Novel subtituted pyrazolo[4, 3-e]diazepines, pharmaceutical compositions containing them, use as medicinal products and processes for preparing them
10/16/2002	EP1248785A1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same
10/16/2002	EP1248781A1 Pyrazole cyclic amp-specific pde inhibitors
10/16/2002	EP1248654A2 Intra-tumoral administration of il-12 encoding nucleic acid molecules
10/16/2002	EP1248650A2 Improved dna vaccines for production-type animals
10/16/2002	EP1248649A2 Use of hemicellulose microparticles as vaccine adjuvant
10/16/2002	EP1248645A1 Novel chimeric proteins and methods for using the same
10/16/2002	EP1248644A1 Method for enhancing the presentation of exogenous antigen by human antigen-presenting cells and opsonized micro particle complexes for applying this
10/16/2002	EP1248630A1 Composition, in particular cosmetic or dermatological composition, containing oligosaccharides and preparation method and cosmetic treatment method
10/16/2002	EP1248624A1 3,4-DIHYDRO-(1H)-QUINAZOLIN-2-ONES AND THEIR USE AS CSBP/p38 KINASE INHIBITORS
10/16/2002	EP1248608A2 Substances for use in treating psoriasis
10/16/2002	EP1248552A1 Pp14 fusion proteins and methods for making and using the same
10/16/2002	EP1248517A2 Clonal propagation of primate offspring by embryo splitting
10/16/2002	EP1248516A2 38 human secreted proteins
10/16/2002	EP1210094A4 Herbal compositions and uses for the treatment of allergic reactions
10/16/2002	EP0991653B1 Novel compounds
10/16/2002	EP0906273B1 Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
10/16/2002	EP0877605B1 Solid instant-release forms of administration and process for producing the same
10/16/2002	EP0831826B1 Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride
10/16/2002	EP0802731B1 Prophylactic treatment of allergic contact dermatitis
10/16/2002	EP0639225B1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology
10/16/2002	EP0538477B1 Novel cyclic aminophenylacetic acid derivative, production thereof, and immune response modulator containing the same as active ingredient
10/16/2002	CN1374966A 嘌呤衍生物 Purine derivatives
10/16/2002	CN1374962A 8-phenyl-6,9-dihydro-[1,2,4]triazolo[3,4-i] purin-5-one derivatives
10/16/2002	CN1374952A Benzimidazolone derivatives and their use as phosphodiesterase inhibibors
10/16/2002	CN1374873A Anionic amino acid based surfactants to enhance antimicrobial effectiveness of topical pharmaceutical compositions
10/16/2002	CN1374872A Stabilization of macrolides
10/16/2002	CN1374871A FC fusion proteins for enhancing the immunogenicity of protein and piptide antigens
10/16/2002	CN1374865A Nociceptin receptor ORL-1 agonists for use in treating cough
10/16/2002	CN1374859A 药物粉剂 Drug powder
10/16/2002	CN1374316A Macrocyclic target specific antisense nucleic acid compound
10/16/2002	CN1374309A Application of cinidium general coumarin as psoriasis treating medicine
10/16/2002	CN1374128A Jiudanhuanxincao herb capsule
10/16/2002	CN1374110A Tonic wine for strengthening body's immunological function
10/16/2002	CN1374080A Prepn and use of composition with cracked disulfide bond
10/16/2002	CN1092712C Process for producing human C36/C46 receptor (CR1) polypeptide
10/16/2002	CN1092659C Novel pyrimidine derivative
10/16/2002	CN1092642C Quinoline derivatives as tachykinin NK 3 receptor antagonists
10/16/2002	CN1092640C Imides as PDE III, PDE IV and TNF inhibitors
10/15/2002	USRE37886 4-(1-(3,5bis(trifluoromethyl) benzoyl)-2-(phenylmethyl)-4-piperidinyl)-n-(2,6dimethylphenyl)-1-piperazine acetamide, having tachykinin and substance p antagonistic activity; analgesic and antiinflammatory agents
10/15/2002	US6465715 Dna fragments from the promoter region of the c. elegans ul6 gene which are capable of functioning as promoters directing gene expression in the excretory cell of c. elegans are provided and also expression vectors and transgenic c. elegans
10/15/2002	US6465518 2-amino-5-fluoro-6-(1-iminoethylamino)-hept-4-enoic acid, for example; treating or preventing various causes of inflammation
10/15/2002	US6465491 6-phenylpyridyl-2-amine derivatives
10/15/2002	US6465479 Pyridomorphinans and use thereof
10/15/2002	US6465471 Cinnamic acid derivatives
10/15/2002	US6465468 Hydroxamic and carboxylic acid derivatives
10/15/2002	US6465455 Benzamide derivatives for the treatment of diseases mediated by cytokines
10/15/2002	US6465441 Screening method for modulation of human mast cell activation
10/15/2002	US6465433 Boronic ester and acid compounds, synthesis and uses
10/15/2002	US6465187 Inhibition of gene expression of antiapoptotic genes to treat mast cell mediated inflammatory disorders
10/15/2002	US6464973 Universal GM-CSF expressing bystander human K562 cell line
10/15/2002	US6464958 Process for the preparation of suspensions of drug particles for inhalation delivery
10/15/2002	CA2145211C The use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases
10/10/2002	WO2002079499A1 Pd-1, a receptor for b7-4, and uses therefor
10/10/2002	WO2002079448A2 G-protein coupled receptors
10/10/2002	WO2002079441A2 Secreted proteins
10/10/2002	WO2002079257A1 Novel compound for treatment of allergy and asthma
10/10/2002	WO2002079255A1 RECOMBINANT ANTIBODIES COEXPRESSED WITH GnTIII
10/10/2002	WO2002079249A2 New polynucleotides and polypeptides of the ifn$g(a)-21 gene
10/10/2002	WO2002079197A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/10/2002	WO2002079194A1 Ccr5 antagonists useful for treating aids
10/10/2002	WO2002079183A1 Halogenated rhodamine derivatives and applications thereof
10/10/2002	WO2002079169A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002	WO2002079168A1 Imidazolyl derivatives useful as histamine h3 receptor ligands
10/10/2002	WO2002079165A1 Tetrahydroquinoline derivatives as stat6-modulators, preparation and use thereof
10/10/2002	WO2002079157A1 Aryl oxime-piperazines useful as ccr5 antagonists
10/10/2002	WO2002079156A1 Novel piperidine derivatives as modulators of chemokine receptor
10/10/2002	WO2002079146A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same

1 ... 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 ... 1172